These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7533350)

  • 1. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1995 Feb; 59(4):637-40. PubMed ID: 7533350
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
    Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
    Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.
    Morrissey PE; Lorber KM; Marcarelli M; Bia MJ; Kliger AS; Lorber MI
    Transplant Proc; 1995 Feb; 27(1):1428-30. PubMed ID: 7533384
    [No Abstract]   [Full Text] [Related]  

  • 4. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of posttransplant B-cell lymphoproliferative disorders.
    Swinnen LJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):21-5. PubMed ID: 10561014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
    Hidalgo M; Lumbreras C; Aguado JM
    Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
    [No Abstract]   [Full Text] [Related]  

  • 7. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
    Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
    Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical detection of Epstein-Barr virus antigens in peripheral B lymphocytes after renal transplantation.
    Hornef MW; Wagner HJ; Fricke L; Bein G; Kirchner H
    Transplantation; 1995 Jan; 59(1):138-40. PubMed ID: 7839415
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-transplant lymphoproliferative disorder.
    Basgoz N; Preiksaitis JK
    Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression.
    Mozzanica N; Cattaneo A; Fracchiolla N; Boneschi V; Berti E; Gronda E; Mangiavacchi M; Finzi AF; Neri A
    J Heart Lung Transplant; 1997 Sep; 16(9):964-8. PubMed ID: 9322148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus. A serial killer or an innocent bystander?
    Sangüeza OP
    Arch Dermatol; 1997 Sep; 133(9):1156-7. PubMed ID: 9301594
    [No Abstract]   [Full Text] [Related]  

  • 12. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
    Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
    Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B; Yousem SA
    Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
    Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
    J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic diagnostic and therapeutic aspects of cytomegalovirus, human herpes virus-6, and Epstein-Barr virus disease posttransplantation.
    Jacobs U; Eis-Hübinger A; Dietrich Miersch W; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3238. PubMed ID: 8962253
    [No Abstract]   [Full Text] [Related]  

  • 18. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
    Rustgi VK
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):100-8. PubMed ID: 9346606
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological aspects of a case of posttransplant lymphoproliferative disorder.
    Franco A; Muñoz C; Aranda I; Cabezas A; Perdiguero M; Prados C
    Am J Nephrol; 1995; 15(2):137-41. PubMed ID: 7733150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.